Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2884-2892
Published online before print May 27, 2008, doi: 10.1161/CIRCULATIONAHA.107.724104
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/22/2884    most recent
CIRCULATIONAHA.107.724104v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heisler, M.
Right arrow Articles by Kerr, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heisler, M.
Right arrow Articles by Kerr, E. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Blood Pressure Medicines
*High Blood Pressure
Related Collections
Right arrow Compliance/Adherence
Right arrow Other hypertension
Right arrowRelated Article

(Circulation. 2008;117:2884-2892.)
© 2008 American Heart Association, Inc.


Health Services and Outcomes Research

When More Is Not Better

Treatment Intensification Among Hypertensive Patients With Poor Medication Adherence

Michele Heisler, MD, MPA; Mary M. Hogan, PhD; Timothy P. Hofer, MD, MS; Julie A. Schmittdiel, PhD; Manel Pladevall, MD; Eve A. Kerr, MD, MPH

From the Veterans Affairs Center for Practice Management and Outcomes Research (M.H., M.M.H., T.P.H., E.A.K.), VA Ann Arbor Health System, Ann Arbor, Mich; Department of Internal Medicine, University of Michigan (M.H., T.P.H., E.A.K.), Ann Arbor, Mich; Michigan Diabetes Research and Training Center (M.H., T.P.H., E.A.K.), Ann Arbor, Mich; Kaiser Permanente Northern California (J.A.S.), Oakland, Calif; and Center for Health Services Research (M.P.), Henry Ford Hospital, Detroit, Mich.

Reprint requests to PO Box 130170, 11H, Ann Arbor, MI 48113-0170. E-mail mheisler{at}umich.edu

Received June 27, 2007; accepted February 8, 2008.

Background— Hypertension may be poorly controlled because patients do not take their medications (poor adherence) or because providers do not increase medication when appropriate (lack of medication intensification, or "clinical inertia"). We examined the prevalence of and relationship between patient adherence and provider treatment intensification.

Methods and Results— We used a retrospective cohort study of hypertensive patients who had filled prescriptions for 1 or more blood pressure (BP) medications at Veterans’ Affairs (VA) healthcare facilities in a Midwestern VA administrative region. Our sample included all patients who received at least 2 outpatient BP medication refills during 2004 and had 1 or more outpatient primary care visits with an elevated systolic BP >140 but <200 mm Hg or diastolic BP >90 mm Hg during 2005 (n=38 327). For each episode of elevated BP during 2005 (68 610 events), we used electronic pharmacy refill data to examine patients’ BP medication adherence over the prior 12 months and whether providers increased doses or added BP medications ("intensification"). Multivariate analyses accounted for the clustering of elevated BP events within patients and adjusted for patient age, comorbidities, number of BP medications, encounter systolic BP, and average systolic BP over the prior year. Providers intensified medications in 30% of the 68 610 elevated BP events, with almost no variation in intensification regardless of whether patients had good or poor BP medication adherence. After adjustment, intensification rates were 31% among patients who had "gaps" of <20% (days on which patients should have had medication but no medication was available because medications had not been refilled), 34% among patients with refill gaps of 20% to 59%, and 32% among patients with gaps of 60% or more.

Conclusions— Intensification of medications occurred in fewer than one third of visits in which patients had an elevated BP. Patients’ prior medication adherence had little impact on providers’ decisions about intensifying medications, even at very high levels of poor adherence. Addressing both patient adherence and provider intensification simultaneously would most likely result in better BP control.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 2841-2843. [Extract] [Full Text]



This article has been cited by other articles:


Home page
HypertensionHome page
A. J. Rose, D. R. Berlowitz, M. Manze, M. B. Orner, and N. R. Kressin
Intensifying Therapy for Hypertension Despite Suboptimal Adherence
Hypertension, September 1, 2009; 54(3): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
A. J. Rose, D. R. Berlowitz, M. Manze, M. B. Orner, and N. R. Kressin
Comparing Methods of Measuring Treatment Intensification in Hypertension Care
Circ Cardiovasc Qual Outcomes, July 1, 2009; 2(4): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. R. Horowitz, M. Robinson, and S. Seifer
Community-Based Participatory Research From the Margin to the Mainstream: Are Researchers Prepared?
Circulation, May 19, 2009; 119(19): 2633 - 2642.
[Abstract] [Full Text] [PDF]